Sonpavde, G P: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

1

Precision medicine for metastatic renal cell carcinoma11Disclosures: Guru Sonpavde, MD: Research support from Novartis, Pfizer, and speaker or advisory board for Novartis, Pfizer, and GSK. Toni K. Choueiri, MD: Research support from Pfizer. Advisory board: Pfizer, Novartis, Aveo, GSK, Bayer/Onyx, and Genentech. No speakers bureau.

Sonpavde, Guru, Choueiri, Toni K.

Journal:

Urologic Oncology: Seminars and Original Investigations

Year:

2014

Language:

english

File:

PDF, 591 KB

english, 2014

2

Treatment-related mortality with vascular endothelial growth factor receptor tyrosine kinase inhibitor therapy in patients with advanced solid tumors: A meta-analysis

Shanthi Sivendran, Ziyue Liu, Louis J. Portas Jr, Menggang Yu, Noah Hahn, Guru Sonpavde, William K. Oh, Matthew D. Galsky

Journal:

Cancer Treatment Reviews

Year:

2012

Language:

english

File:

PDF, 298 KB

english, 2012

3

Update on Systemic Prostate Cancer Therapies: Management of Metastatic Castration-resistant Prostate Cancer in the Era of Precision Oncology

Nuhn, Philipp, De Bono, Johann S., Fizazi, Karim, Freedland, Stephen J., Grilli, Maurizio, Kantoff, Philip W., Sonpavde, Guru, Sternberg, Cora N., Yegnasubramanian, Srinivasan, Antonarakis, Emmanuel S

Journal:

European Urology

Year:

2018

Language:

english

File:

PDF, 650 KB

english, 2018

4

The effect of treatment at minority-serving hospitals on outcomes for bladder cancer

Fletcher, Sean A., Gild, Philipp, Cole, Alexander P., Vetterlein, Malte W., Kibel, Adam S., Choueiri, Toni K., Sonpavde, Guru P., Preston, Mark A., Pucheril, Daniel, Menon, Mani, Sun, Maxine, Lipsitz,

Journal:

Urologic Oncology: Seminars and Original Investigations

Year:

2018

Language:

english

File:

PDF, 430 KB

english, 2018

5

Improving the Cost Efficiency of PD-1/PD-L1 Inhibitors for Advanced Urothelial Carcinoma: A Major Role for Precision Medicine?

Sonpavde, Guru, Dranitsaris, George, Necchi, Andrea

Journal:

European Urology

Year:

2018

Language:

english

File:

PDF, 130 KB

english, 2018

6

Management of Castrate Resistant Prostate Cancer—Recent Advances and Optimal Sequence of Treatments

Zhang, Tian Yi, Agarwal, Neeraj, Sonpavde, Guru, DiLorenzo, Giuseppe, Bellmunt, Joaquim, Vogelzang, Nicholas J.

Journal:

Current Urology Reports

Year:

2013

Language:

english

File:

PDF, 265 KB

english, 2013

7

Impact of prednisone on toxicities and survival in metastatic castration-resistant prostate cancer: A systematic review and meta-analysis of randomized clinical trials

Morgan, Charity J., Oh, William K., Naik, Gurudatta, Galsky, Matthew D., Sonpavde, Guru

Journal:

Critical Reviews in Oncology/Hematology

Year:

2014

Language:

english

File:

PDF, 1.30 MB

english, 2014

8

Meta-analysis of regression of advanced solid tumors in patients receiving placebo or no anti-cancer therapy in prospective trials

Ghatalia, Pooja, Morgan, Charity J., Sonpavde, Guru

Journal:

Critical Reviews in Oncology/Hematology

Year:

2016

Language:

english

File:

PDF, 2.17 MB

english, 2016

9

Re: Immediate Versus Deferred Chemotherapy After Radical Cystectomy in Patients with pT3-pT4 or N+ M0 Urothelial Carcinoma of the Bladder (EORTC 30994): An Intergroup, Open-label, Randomised Phase 3 Trial

Sonpavde, Guru, Pal, Sumanta

Journal:

European Urology

Year:

2016

Language:

english

File:

PDF, 71 KB

english, 2016

10

Emerging Systemic Therapies for the Management of Penile Cancer

Gupta, Shilpa, Sonpavde, Guru

Journal:

Urologic Clinics of North America

Year:

2016

Language:

english

File:

PDF, 612 KB

english, 2016

11

Nomogram-based Prediction of Overall Survival in Patients with Metastatic Urothelial Carcinoma Receiving First-line Platinum-based Chemotherapy: Retrospective International Study of Invasive/Advanced Cancer of the Urothelium (RISC)

Necchi, Andrea, Sonpavde, Guru, Lo Vullo, Salvatore, Giardiello, Daniele, Bamias, Aristotelis, Crabb, Simon J., Harshman, Lauren C., Bellmunt, Joaquim, De Giorgi, Ugo, Sternberg, Cora N., Cerbone, Lin

Journal:

European Urology

Year:

2017

Language:

english

File:

PDF, 1.34 MB

english, 2017

12

Utility of cell-free nucleic acid and circulating tumor cell analyses in prostate cancer

Gourdin, Theodore, Sonpavde, Guru

Journal:

Asian Journal of Andrology

Year:

2018

Language:

english

File:

PDF, 578 KB

english, 2018

13

Expression and Role of Methylenetetrahydrofolate Dehydrogenase 1 Like (MTHFD1L) in Bladder Cancer

Eich, Marie-Lisa, Rodriguez Pena, Maria Del Carmen, Chandrashekar, Darshan Shimoga, Chaux, Alcides, Agarwal, Sumit, Gordetsky, Jennifer B., Ferguson, James E., Sonpavde, Guru P., Netto, George J., Var

Journal:

Translational Oncology

Year:

2019

Language:

english

File:

PDF, 768 KB

english, 2019

14

Evaluating the cost of surveillance for non-muscle invasive bladder cancer: An economic analysis based on risk categories

Mossanen, M., Wang, Y., Szymaniak, J., Tan, W.S., Huynh, M.J., Preston, M.A., Trinh, Q-D., Sonpavde, G., Schrag, D., Kibel, A.S., Chang, S.L.

Journal:

European Urology Supplements

Year:

2019

File:

PDF, 86 KB

2019

15

Expression of estrogen receptors-α and -β in bladder cancer cell lines and human bladder tumor tissue

Steven S. Shen, Carolyn L. Smith, Jer-Tsong Hsieh, Jiang Yu, Isaac Y. Kim, Weiguo Jian, Guru Sonpavde, Gustavo E. Ayala, Mamoun Younes, Seth P. Lerner

Journal:

Year:

2006

Language:

english

File:

PDF, 306 KB

english, 2006

16

Neoadjuvant therapy followed by prostatectomy for clinically localized prostate cancer

Guru Sonpavde, Kim N. Chi, Thomas Powles, Christopher J. Sweeney, Noah Hahn, Thomas E. Hutson, Matthew D. Galsky, William R. Berry, Dov Kadmon

Journal:

Year:

2007

Language:

english

File:

PDF, 134 KB

english, 2007

17

Reply to neoadjuvant therapy followed by prostatectomy for clinically localized prostate cancer

Guru Sonpavde, Mark Garzotto, Kim N. Chi

Journal:

Year:

2008

Language:

english

File:

PDF, 41 KB

english, 2008

18

Quality of pathologic response and surgery correlate with survival for patients with completely resected bladder cancer after neoadjuvant chemotherapy

Guru Sonpavde, Bryan H. Goldman, V. O. Speights, Seth P. Lerner, David P. Wood, Nicholas J. Vogelzang, Donald L. Trump, Ronald B. Natale, H. Barton Grossman, E. David Crawford

Journal:

Year:

2009

Language:

english

File:

PDF, 188 KB

english, 2009

19

A validated prognostic index predicting response to dexamethasone and diethylstilbestrol in castrate-resistant prostate cancer

Jonathan Shamash, Justin Stebbing, Chris Sweeney, Guru Sonpavde, Steve Harland, Guy Dawkins, Cathryn Brock, Walter Abelman, Peter Wilson, Adam Sanitt, Tim Oliver, Thomas Powles

Journal:

Year:

2010

Language:

english

File:

PDF, 223 KB

english, 2010

20

The association between radiographic response and overall survival in men with metastatic castration-resistant prostate cancer receiving chemotherapy

Guru Sonpavde, Gregory R. Pond, William R. Berry, Ronald de Wit, Mario A. Eisenberger, Ian F. Tannock, Andrew J. Armstrong

Journal:

Year:

2011

Language:

english

File:

PDF, 293 KB

english, 2011

21

Preoperative chemotherapy for bladder cancer : A standard waits to be optimally deployed

Guru Sonpavde, Shahrokh F. Shariat

Journal:

Year:

2012

Language:

english

File:

PDF, 80 KB

english, 2012

22

Neoadjuvant therapy as a paradigm to develop systemic cancer therapy

Journal:

Drug Development Research

Year:

2008

Language:

english

File:

PDF, 112 KB

english, 2008

23

Perioperative chemotherapy for bladder cancer

Guru Sonpavde, Daniel P. Petrylak

Journal:

Critical Reviews in Oncology/Hematology

Year:

2006

Language:

english

File:

PDF, 131 KB

english, 2006

24

Target-specific randomized discontinuation trial design: a novel approach in molecular therapeutics

Matthew D. Galsky, Tal Zaks, Habib Hassani, Linda Vocila, Guru Sonpavde, Thomas E. Hutson, Daniel D. Von Hoff

Journal:

Investigational New Drugs

Year:

2010

Language:

english

File:

PDF, 141 KB

english, 2010

25

Pazopanib: A novel multitargeted tyrosine kinase inhibitor

Guru Sonpavde, Thomas E. Hutson

Journal:

Current Oncology Reports

Year:

2007

Language:

english

File:

PDF, 752 KB

english, 2007

26

Everolimus for renal cell carcinoma: predictive factors for response and future directions

Guru Sonpavde, Thomas E. Hutson

Journal:

Medical Oncology

Year:

2009

Language:

english

File:

PDF, 348 KB

english, 2009

27

The role of docetaxel based therapy for prostate cancer in the era of targeted medicine

Guru Sonpavde, Cora N Sternberg

Journal:

International Journal of Urology

Year:

2010

Language:

english

File:

PDF, 180 KB

english, 2010

28

Novel agents for muscle-invasive and advanced urothelial cancer

Guru Sonpavde, Robert Ross, Thomas Powles, Christopher J. Sweeney, Noah Hahn, Thomas E. Hutson, Matthew D. Galsky, Seth P. Lerner, Cora N. Sternberg

Journal:

BJU International

Year:

2008

Language:

english

File:

PDF, 120 KB

english, 2008

29

Treatment of metastatic urothelial cancer: opportunities for drug discovery and development

Guru Sonpavde, Cora N. Sternberg

Journal:

BJU International

Year:

2008

Language:

english

File:

PDF, 115 KB

english, 2008

30

Neoadjuvant systemic therapy for urological malignancies

Guru Sonpavde, Cora N. Sternberg

Journal:

BJU International

Year:

2010

Language:

english

File:

PDF, 583 KB

english, 2010

31

Prognostic risk stratification of pathological stage T2N0 bladder cancer after radical cystectomy

Guru Sonpavde, Myrna M. Khan, Robert S. Svatek, Richard Lee, Giacomo Novara, Derya Tilki, Seth P. Lerner, Gilad E. Amiel, Eila Skinner, Pierre I. Karakiewicz, Patrick J. Bastian, Wassim Kassouf, Hans-

Journal:

BJU International

Year:

2011

Language:

english

File:

PDF, 337 KB

english, 2011

32

Axitinib for renal cell carcinoma

Sonpavde, Guru, Hutson, Thomas E, Rini, Brian I

Journal:

Expert Opinion on Investigational Drugs

Year:

2008

Language:

english

File:

PDF, 353 KB

english, 2008

33

Prevalence and characteristics of patients with metastatic cancer who receive no anticancer therapy

Alexander C. Small, Che-Kai Tsao, Erin L. Moshier, Benjamin A. Gartrell, Juan P. Wisnivesky, James H. Godbold, Cardinale B. Smith, Guru Sonpavde, William K. Oh, Matthew D. Galsky

Journal:

Year:

2012

Language:

english

File:

PDF, 755 KB

english, 2012

34

The activity of the androgen receptor variant AR-V7 is regulated by FOXO1 in a PTEN-PI3K-AKT-dependent way

Sanjay N. Mediwala, Huiying Sun, Adam T. Szafran, Sean M. Hartig, Guru Sonpavde, Teresa G. Hayes, Perumal Thiagarajan, Michael A. Mancini, Marco Marcelli

Journal:

Year:

2012

Language:

english

File:

PDF, 639 KB

english, 2012

35

The Double Edged Sword of Bleeding and Clotting from VEGF Inhibition in Renal Cancer Patients

Guru Sonpavde, Joaquim Bellmunt, Fabio Schutz, Toni K. Choueiri

Journal:

Current Oncology Reports

Year:

2012

Language:

english

File:

PDF, 330 KB

english, 2012

36

Neoadjuvant Chemotherapy for Invasive Bladder Cancer

Guru Sonpavde, Cora N. Sternberg

Journal:

Current Urology Reports

Year:

2012

Language:

english

File:

PDF, 276 KB

english, 2012

37

Association of Rash With Outcomes in a Randomized Phase II Trial Evaluating Cetuximab in Combination With Mitoxantrone Plus Prednisone After Docetaxel for Metastatic Castration-resistant Prostate Cancer

Mark T. Fleming, Guru Sonpavde, Michael Kolodziej, Sanjay Awasthi, Thomas E. Hutson, Danko Martincic, Ashutosh Rastogi, Steven R. Rousey, Ralph E. Weinstein, Matthew D. Galsky, William R. Berry, Yunfe

Journal:

Clinical Genitourinary Cancer

Year:

2012

Language:

english

File:

PDF, 434 KB

english, 2012

38

Administration of Cisplatin-Based Chemotherapy for Advanced Urothelial Carcinoma in the Community

Guru Sonpavde, Deidre Watson, Marcia Tourtellott, C. Lance Cowey, Beth Hellerstedt, Thomas E. Hutson, Feng Zhan, Nicholas J. Vogelzang

Journal:

Clinical Genitourinary Cancer

Year:

2012

Language:

english

File:

PDF, 232 KB

english, 2012

39

Validation of the AJCC TNM Substaging of pT2 Bladder Cancer: Deep Muscle Invasion Is Associated with Significantly Worse Outcome

Derya Tilki, Oliver Reich, Pierre I. Karakiewicz, Giacomo Novara, Wassim Kassouf, Süleyman Ergün, Yves Fradet, Vincenzo Ficarra, Guru Sonpavde, Christian G. Stief, Eila Skinner, Robert S. Svatek, Yair

Journal:

European Urology

Year:

2010

Language:

english

File:

PDF, 249 KB

english, 2010

40

The Role of Abiraterone Acetate in the Management of Prostate Cancer: A Critical Analysis of the Literature

Guru Sonpavde, Gerhardt Attard, Joaquim Bellmunt, Malcolm D. Mason, Bernard Malavaud, Bertrand Tombal, Cora N. Sternberg

Journal:

European Urology

Year:

2011

Language:

english

File:

PDF, 209 KB

english, 2011

41

Evaluating the Value of Number of Cycles of Docetaxel and Prednisone in Men With Metastatic Castration-Resistant Prostate Cancer

Gregory R. Pond, Andrew J. Armstrong, Brian A. Wood, Melissa Brookes, Lance Leopold, William R. Berry, Ronald de Wit, Mario A. Eisenberger, Ian F. Tannock, Guru Sonpavde

Journal:

European Urology

Year:

2012

Language:

english

File:

PDF, 1.38 MB

english, 2012

42

Reply to YiJun Shen and DingWei Ye's Letter to the Editor re: Gregory R. Pond, Andrew J. Armstrong, Brian A. Wood, et al. Evaluating the Value of Number of Cycles of Docetaxel and Prednisone in Men With Metastatic Castration-Resistant Prostate Cancer. Eur Urol 2012;61:363–9

Guru Sonpavde, Gregory R. Pond, Andrew J. Armstrong

Journal:

European Urology

Year:

2012

Language:

english

File:

PDF, 75 KB

english, 2012

43

Sequencing of Agents for Metastatic Renal Cell Carcinoma: Can We Customize Therapy?

Guru Sonpavde, Toni K. Choueiri, Bernard Escudier, Vincenzo Ficarra, Thomas E. Hutson, Peter F. Mulders, Jean-Jacques Patard, Brian I. Rini, Michael Staehler, Cora N. Sternberg, Christian G. Stief

Journal:

European Urology

Year:

2012

Language:

english

File:

PDF, 317 KB

english, 2012

44

The Role of Sipuleucel-T in Therapy for Castration-Resistant Prostate Cancer: A Critical Analysis of the Literature

Guru Sonpavde, Giuseppe Di Lorenzo, Celestia S. Higano, Philip W. Kantoff, Ravi Madan, Neal D. Shore

Journal:

European Urology

Year:

2012

Language:

english

File:

PDF, 742 KB

english, 2012

45

Novel Molecular Targets for the Therapy of Castration-Resistant Prostate Cancer

Neeraj Agarwal, Guru Sonpavde, Cora N. Sternberg

Journal:

European Urology

Year:

2012

Language:

english

File:

PDF, 596 KB

english, 2012

46

Reply form Authors re: Bertrand Tombal. Continuous Improvement Versus Innovation: The Case for Sipuleucel-T. Eur Urol 2012;61:648–9

Guru Sonpavde, Giuseppe Di Lorenzo, Celestia S. Higano, Philip W. Kantoff, Ravi A. Madan, Neal D. Shore

Journal:

European Urology

Year:

2012

Language:

english

File:

PDF, 61 KB

english, 2012

47

Objective Evaluation of Bone Metastases in Prostate Cancer: To What End?

Guru Sonpavde, Andrew J. Armstrong

Journal:

European Urology

Year:

2012

Language:

english

File:

PDF, 96 KB

english, 2012

48

Systemic Chemotherapy for Urothelial Cancer

Guru Sonpavde, Thomas E. Hutson, William R. Berry

Journal:

Clinical Genitourinary Cancer

Year:

2006

Language:

english

File:

PDF, 145 KB

english, 2006

49

Phase II Study of Azacitidine to Restore Responsiveness of Prostate Cancer to Hormonal Therapy

Guru Sonpavde, Ana Aparicio, Israel Guttierez, Kristi A. Boehm, Thomas E. Hutson, William R. Berry, Lina Asmar, Daniel D. von Hoff

Journal:

Clinical Genitourinary Cancer

Year:

2007

Language:

english

File:

PDF, 99 KB

english, 2007

50

Phase II Trial of Sunitinib for the Therapy of Progressive Metastatic Castration-Refractory Prostate Cancer After Previous Docetaxel Chemotherapy

Guru Sonpavde, Thomas E. Hutson, William R. Berry, Kristi A. Boehm, Lina Asmar

Journal:

Clinical Genitourinary Cancer

Year:

2008

Language:

english

File:

PDF, 93 KB

english, 2008